AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2014
Feb 26, 2014
30870_dirs_2014-02-26_1e9c0257-b139-4542-95bf-65c5f20af963.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2014-02-24
Reporting Person: Malik Fady Ibraham (SVP Research & Early Dev)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-24 | Incentive Stock Option (right to buy) | $9.65 | A | 13987 | Acquired | 2024-02-24 | Common Stock (13987) | Direct |
| 2014-02-24 | Non-Qualified Stock Option (right to buy) | $9.65 | A | 86013 | Acquired | 2024-02-24 | Common Stock (86013) | Direct |
Footnotes
F1: When the ISO and NQ dated 02/24/2014 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 100,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/24/2018.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18